UBS Lux Equity Fund Biotech USD vs Protean Select

UBS Lux Equity Fund Biotech USD vs Protean Select

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    5

2. Protean Select

  • Security

    Protean Select

  • Fee

    2.60%

  • ISIN

    SE0017830748

  • Holdings

    8

Fund Holdings

We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with Protean Select, we have 9 holdings where RaySearch is the largest holding (4.07), followed by Devyser Diagnostics (3.18) and Acast (3.11).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Protean Select.

UBS Lux Equity Fund Biotech USD Protean Select
1. Regeneron Pharmaceuticals Inc
10.04 %		 1. RaySearch Laboratories B
Sweden
4.07 %
2. Moderna Inc
9.21 %		 2. Devyser Diagnostics AB
Sweden
3.18 %
3. Gilead Sciences Inc
USA
4.66 %		 3. Acast AB
Sweden
3.11 %
4. BioNTech SE
4.13 %		 4. MEKO Sweden AB
Sweden
2.29 %
5. Karuna Therapeutics Inc
3.75 %		 5. Coor Service Management Holding
2.21 %
- 6. Lagercrantz Group B
Sweden
2.19 %
- 7. Novo Nordisk B
Denmark
2.08 %
- 8. Indutrade AB
Sweden
2.07 %

The list of fund holdings was last updated on September 10, 2025.